MEDB-81. Combined inhibition of CDK11 and EZH2 results in regression of MYC-amplified medulloblastoma

Authors: Dong Wang, Bethany Veo, Angela Pierce, Sujatha Venkataraman, Rajeev Vibhakar

Published: 2022-06-03

DOI: 10.1093/neuonc/noac079.455

Source: Full article